What is Celcuity's other accrued liabilities?

Celcuity (CELC) reported other accrued liabilities of $13.97M in Q1 2026.

What is the long-term trend for Celcuity's other accrued liabilities?

Over 2 years (2020 to 2025), Celcuity's other accrued liabilities has grown at a 1134.0% compound annual growth rate (CAGR), from $137.02K to $20.87M.

Celcuity CELC Other accrued liabilities

Other accrued liabilities at other companies

BridgeBio PharmaBBIO

——

Tango TherapeuticsTNGX

——

Medpace Holdings, Inc.MEDP

——

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

See full

Operating income-$50.5M-39.8%

Net income-$52.8M-42.8%

EPS (diluted)-$0.97-12.8%

Balance sheet

See full

Cash & equivalents$145.2M+781%

Total debt$137.9M+30.7%

Total equity$53.5M-38.2%

Total assets$410.2M+88.0%

Cash flow

See full

Operating cash flow-$55.1M-53.6%

CapEx$249.0K+315%

Free cash flow-$55.3M-54.0%

Valuation

See full

Market cap$4.4B+1,370%

Returns & leverage

See full

Return on equity-275.2%-990pp

Debt / equity2.6×+1.4×

Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celcuity's other accrued liabilities?: Celcuity (CELC) reported other accrued liabilities of $13.97M in Q1 2026.
What is the long-term trend for Celcuity's other accrued liabilities?: Over 2 years (2020 to 2025), Celcuity's other accrued liabilities has grown at a 1134.0% compound annual growth rate (CAGR), from $137.02K to $20.87M.